Toxicity on Dengue Mosquito Vectors Through Myristica fragrans-Synthesized Zinc Oxide Nanorods, and Their Cytotoxic Effects on Liver Cancer Cells (HepG2)
Dengue is an arbovirus mainly vectored by Aedes mosquitoes. Its prevention and control depends to effective vector control measures. Cancer causes millions of death every year. Most of the anticancer drugs have high toxicity and low specificity of action, leading to systemic toxicity and severe side...
Gespeichert in:
Veröffentlicht in: | Journal of cluster science 2017, Vol.28 (1), p.205-226 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Dengue is an arbovirus mainly vectored by
Aedes
mosquitoes. Its prevention and control depends to effective vector control measures. Cancer causes millions of death every year. Most of the anticancer drugs have high toxicity and low specificity of action, leading to systemic toxicity and severe side effects. Thus, the development of effective tools is a priority. We fabricated zinc oxide nanoparticles using the
Myristica fragrans
extract as a reducing and stabilizing agent. Nanoparticles were studied using UV–vis spectrophotometry, Fourier transform infrared spectroscopy, X-ray diffraction, zeta potential, dynamic light scattering, energy dispersive X-ray analysis, field emission scanning electron microscopy and transmission electron microscopy. ZnO nanorods were highly effective against
A. aegypti
young instars, with LC
50
ranging from 3.44 (larva I) to 14.63 ppm (pupa). Nanorods showed adult LC
50
of 15.004 ppm. ZnO nanorods exhibited dose-dependent cytotoxicity against human hepato-cancer cells (HepG2). After 48 and 24 h of incubation, the IC
50
were 20 and 22 μg/ml, respectively. Nanorods triggered the induction of apoptosis. Overall, this study highlights that the possibility to employ
M. fragrans
-synthesized ZnO nanorods in mosquito control, as well as in the development of novel chemotherapeutic agents with reduced systemic toxicity. |
---|---|
ISSN: | 1040-7278 1572-8862 |
DOI: | 10.1007/s10876-016-1075-y |